Ketamine-xylazine anaesthesia and orofacial administration of substance P: A lethal combination in rats.

Autor: Francischi JN; Department of Pharmacology, Biological Sciences Institute, Federal University of Minas Gerais, Brazil. Electronic address: janettinogueirade.francischi@gmail.com., Frade TIC; Department of Pharmacology, Biological Sciences Institute, Federal University of Minas Gerais, Brazil., Almeida MPA; Department of Pharmacology, Biological Sciences Institute, Federal University of Minas Gerais, Brazil., Queiroz BFG; Department of Pharmacology, Biological Sciences Institute, Federal University of Minas Gerais, Brazil., Bakhle YS; Division of Leukocyte Biology, Imperial College London, England.
Jazyk: angličtina
Zdroj: Neuropeptides [Neuropeptides] 2017 Apr; Vol. 62, pp. 21-26. Date of Electronic Publication: 2017 Jan 23.
DOI: 10.1016/j.npep.2017.01.003
Abstrakt: Background and Aims: Ketamine+xylazine mixture is a widely used anaesthetic in animal experiments. In rats anaesthetized with this mixture, we have shown that injection of carrageenan, a standard proinflammatory stimulus, into the cheek (intra-oral injection) induced oedema. A likely mediator of this oedema is substance P (SP), a major transmitter of sensory nerves in orofacial tissue. We have assessed the effects of intra-oral injection of SP in rats.
Experimental Approach: SP (50-1μg per rat) was injected intra-orally in male adult Holtzman or Wistar rats, anaesthetized with ketamine+xylazine. For comparison, histamine (50μg) and 5-HT (5μg) were similarly injected. Antagonists of SP (SR140333, 2mg/kg), of histamine (pyrilamine, 2mg/kg) or of 5-HT (pizotifen, 2mg/kg) were subcutaneously (s.c.) injected, 30min before the corresponding agonist. Oedema in the cheek was assessed by measuring tissue thickness with calipers.
Results: Intra-oral injection of SP (1-50μg per rat) in Holtzman or Wistar rats anaesthetized with ketamine+xylazine induced, dose-dependently, death within 15min, accompanied by signs of excessive salivation. Rats pretreated with SR140333 were protected against SP-induced lethality and the excessive salivation. However, intra-oral injection of either histamine or 5-HT did not induce death, only a characteristic cheek oedema. These doses of SP injected into the hindpaws of conscious Holtzman and Wistar rats only induced oedema with no deaths. In rats anaesthetized with inhaled isoflurane, intra-oral SP (50μg) induced only cheek oedema, with no deaths or excessive salivation. This oedema was prevented by pre-treating rats with SR140333, pyrilamine and pizotifen.
Conclusion: It is likely that the deaths were due to excessive salivation induced by the particular combination of ketamine and SP. Our results are presented as a warning to other experimenters who might use these two otherwise non-toxic conditions and the consequent unexpected and needless loss of experimental animals.
(Copyright © 2017 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: